An improved, scalable synthesis of the selective serotonin 2A receptor agonist 25CN-NBOH
Keyword(s):
4-(2-((2-hydroxybenzyl)amino)ethyl)-2,5-dimethoxybenzonitrile (25CN-NBOH) was first reported as a potent and highly selective serotonin 2A receptor (5-HT2AR) agonist in 2014. The compound has since found extensive use as a pharmacological tool in a variety of in vivo and in vitro studies. In the present study, we present an improved and scalable synthesis of 25CN-NBOH making this compound readily available to the scientific community.
1999 ◽
Vol 51
(4-5)
◽
pp. 309-314
◽
1993 ◽
Vol 77
(6)
◽
pp. 1662-1666
1981 ◽
Vol 25
(2)
◽
pp. 179-183
◽
1993 ◽
Vol 77
(6)
◽
pp. 1662-1666
◽
1969 ◽
Vol 21
(02)
◽
pp. 234-244
◽
Keyword(s):